{
  "source": "mock_internal",
  "bullets": [
    "Field team reported increased usage trends in chronic patients.",
    "Opportunity: Improved formulation may provide advantage in Tier-2 markets.",
    "Competitor analysis indicates pricing pressure but strong prescription loyalty.",
    "Pharmacovigilance notes minimal adverse trends year-over-year."
  ]
}